Review of multitude of preclinical and clinical studies support the repurposing of atomoxetine for Alzheimers Disease(AD) drug development for both symptoms and neuroprotection to slow disease progression

GLP-1 Drugs Tirzepatide and Semaglutide Provide Protection for Heart Health

Study suggests that maternal treatment with SSRIs during breastfeeding does not affect the cognitive performance of the offspring.

New study finds 11% nationwide decline in rural family physicians

Study: Cannabis Treatment Provides Sustained Relief for Patients With Fibromyalgia

Laughing Gas Can Offer Immediate Relief From Depression

NU-9 halts Alzheimer’s disease in animal model before symptoms begin: « Study uncovers a new Alzheimer’s trigger — and a way to stop it. »

Systematic review and meta analysis finds that Individuals with ADHD treated with stimulants have a non-negligible risk of developing psychosis or bipolar disorder, with a higher risk associated with amphetamines compared to methylphenidate.

An experimental vaccine protects genetically modified humanized mice against anaphylaxis and severe allergic reactions for up to a year

Study Illuminates How an Antiviral Defense Mechanism May Lead to Alzheimer’s Disease